These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 27593244)
1. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer. Platzek I PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244 [TBL] [Abstract][Full Text] [Related]
2. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264 [TBL] [Abstract][Full Text] [Related]
3. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410 [TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer. Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545 [TBL] [Abstract][Full Text] [Related]
6. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295 [TBL] [Abstract][Full Text] [Related]
7. FDG PET/MR for lymph node staging in head and neck cancer. Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792 [TBL] [Abstract][Full Text] [Related]
8. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Kitajima K; Suenaga Y; Sugimura K Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982 [TBL] [Abstract][Full Text] [Related]
9. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512 [TBL] [Abstract][Full Text] [Related]
10. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area? Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955 [TBL] [Abstract][Full Text] [Related]
11. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma. Platzek I PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243 [TBL] [Abstract][Full Text] [Related]
12. PET-MR Imaging in Head and Neck. Lee YZ; Ramalho J; Kessler B Magn Reson Imaging Clin N Am; 2017 May; 25(2):315-324. PubMed ID: 28390531 [TBL] [Abstract][Full Text] [Related]
13. A preliminary report on the impact of ¹⁸F-FDG PET/CT in the management of paediatric head and neck cancer. Boktor RR; Omar WS; Mousa E; Attia I; Refaat A; Eltawdy MH; Pitman AG; Abdel-Dayem HM Nucl Med Commun; 2012 Jan; 33(1):21-8. PubMed ID: 21968431 [TBL] [Abstract][Full Text] [Related]
14. Normal Patterns and Pitfalls of FDG Uptake in the Head and Neck. Gray BR; Koontz NA Semin Ultrasound CT MR; 2019 Oct; 40(5):367-375. PubMed ID: 31635764 [TBL] [Abstract][Full Text] [Related]
15. (18)F FDG PET/CT versus CT/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma. Park JT; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2016 May; 279(2):481-91. PubMed ID: 26653682 [TBL] [Abstract][Full Text] [Related]
16. The value of fluorine-18 fluorodeoxyglucose PET/MRI in the diagnosis of head and neck carcinoma: a meta-analysis. Xiao Y; Chen Y; Shi Y; Wu Z Nucl Med Commun; 2015 Apr; 36(4):312-8. PubMed ID: 25514551 [TBL] [Abstract][Full Text] [Related]
17. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes. Sheikhbahaei S; Marcus C; Subramaniam RM PET Clin; 2015 Apr; 10(2):125-45. PubMed ID: 25829083 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
19. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging. Højgaard L; Berthelsen AK; Loft A PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278 [TBL] [Abstract][Full Text] [Related]
20. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]